Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China
· Delayed Price · Currency is CNY 5.62
-0.19 (-3.27%)
Apr 30, 2025, 3:04 PM CST
SHE:002082 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 45.25 | 49.21 | 93.26 | 166.51 | 284.94 | Upgrade
|
| Depreciation & Amortization | 104.12 | 95.42 | 107.03 | 94.98 | 107.11 | Upgrade
|
| Other Amortization | 2.94 | 3.23 | 1.2 | 1.24 | 5.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | -15.74 | -0.12 | 0.95 | 1.21 | 0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 24.23 | 2.88 | 90.27 | 47.37 | 76.36 | Upgrade
|
| Loss (Gain) From Sale of Investments | -17.29 | -0.66 | 0.06 | -229.65 | -13.17 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 23.56 | 38.98 | 52.25 | 19.4 | Upgrade
|
| Other Operating Activities | 37.6 | 31.86 | 18.16 | 51.07 | 77.1 | Upgrade
|
| Change in Accounts Receivable | 12.88 | -15.2 | -101.79 | 178.83 | -626.94 | Upgrade
|
| Change in Inventory | 54.58 | 20.81 | -18.71 | 64.52 | -64.78 | Upgrade
|
| Change in Accounts Payable | -110.89 | -262.25 | -438.51 | -390.96 | 309.05 | Upgrade
|
| Operating Cash Flow | 120.22 | -72.87 | -239.65 | 22.09 | 151.01 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -85.38% | - | Upgrade
|
| Capital Expenditures | -88.43 | -128.72 | -167.23 | -285.51 | -559.24 | Upgrade
|
| Sale of Property, Plant & Equipment | 49.45 | 0.2 | 4.3 | 0.27 | 1.34 | Upgrade
|
| Cash Acquisitions | -10.54 | -40 | - | - | -79.9 | Upgrade
|
| Divestitures | - | - | - | 1,293 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -4.96 | -13.1 | - | Upgrade
|
| Investment in Securities | -109.29 | 2.49 | - | - | -39.8 | Upgrade
|
| Other Investing Activities | 6.33 | 5.95 | -1.15 | 5.07 | -3.04 | Upgrade
|
| Investing Cash Flow | -152.49 | -156.03 | -167.42 | 999.46 | -680.64 | Upgrade
|
| Short-Term Debt Issued | - | 0.03 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 1,083 | 875.92 | 720.22 | 581.49 | 1,629 | Upgrade
|
| Total Debt Issued | 1,083 | 875.95 | 720.22 | 581.49 | 1,629 | Upgrade
|
| Long-Term Debt Repaid | -1,031 | -764.53 | -712.42 | -1,014 | -1,271 | Upgrade
|
| Total Debt Repaid | -1,031 | -764.53 | -712.42 | -1,014 | -1,271 | Upgrade
|
| Net Debt Issued (Repaid) | 51.9 | 111.42 | 7.8 | -432.13 | 358.02 | Upgrade
|
| Repurchase of Common Stock | - | - | -9.03 | -50.96 | - | Upgrade
|
| Common Dividends Paid | -90.84 | -122.03 | -43.91 | -191.66 | -170.77 | Upgrade
|
| Other Financing Activities | -3.39 | 19.86 | -17.93 | - | 252.36 | Upgrade
|
| Financing Cash Flow | -42.33 | 9.26 | -63.07 | -674.75 | 439.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.16 | -1.25 | 2.02 | -5.44 | 2.94 | Upgrade
|
| Net Cash Flow | -74.76 | -220.89 | -468.11 | 341.35 | -87.09 | Upgrade
|
| Free Cash Flow | 31.79 | -201.59 | -406.88 | -263.42 | -408.24 | Upgrade
|
| Free Cash Flow Margin | 2.20% | -13.07% | -22.78% | -13.64% | -2.98% | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.33 | -0.65 | -0.43 | -0.67 | Upgrade
|
| Cash Income Tax Paid | 119.95 | 133.12 | 402.31 | 175.69 | 192.92 | Upgrade
|
| Levered Free Cash Flow | 87 | 44.08 | -373.4 | 800.46 | -340.2 | Upgrade
|
| Unlevered Free Cash Flow | 87 | 73.13 | -352.66 | 822.72 | -304.77 | Upgrade
|
| Change in Net Working Capital | -12.68 | -59.33 | 434.07 | -893.44 | 131.55 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.